Champions Oncology CSBR Cash Flow Statement (2010-2026)

NASDAQ CSBR
$5.01 -0.09 (-1.76%)
As of: Sep 9, 2026 · 3:58 PM EDT
Reported Financials

Champions Oncology Quarterly Cash Flow Statement

Periods 64 quarters
Latest Apr 2026

Champions Oncology reported cash from operations of -$2.00M and free cash flow of -$2.24M for the quarter ended Apr 2026, down 129.1% year over year. This cash flow statement covers 64 quarters of results from Jul 2010 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income
-0.17M0.28M0.79M-0.34M-0.32M-0.02M-2.44M-2.56M-2.57M-2.07M-2.53M-0.11M1.31M0.73M4.50M-1.83M-0.47M0.24M-0.28M-0.67M
Share-based CompensationStock Comp.
0.28M0.13M0.31M0.19M0.21M0.12M0.33M0.21M0.42M0.05M0.38M0.26M0.26M0.01M0.26M0.13M0.21M0.25M0.42M0.36M
Asset Writedowns and ImpairmentWritedown
0.13M-0.05M0.72M0.16M0.07M0.08M0.16M-0.07M-0.21M-0.04M0.05M-0.03M0.01M-0.03M0.07M
Cash from OperationsCash from Ops.
0.22M1.23M4.26M0.80M-0.20M3.29M1.57M-0.69M-3.99M0.59M-0.92M-1.82M0.31M-0.28M0.49M6.87M0.60M-1.74M-1.34M-2.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.32M0.35M0.40M0.57M0.53M0.56M0.57M0.58M0.45M0.48M0.48M0.46M0.45M0.40M0.40M0.39M0.36M0.36M0.34M0.32M
Change in Working Capital
Change in ReceivablesChange Receivables
0.82M0.50M0.37M1.12M-0.16M-0.28M-0.94M0.07M1.10M-1.15M0.25M1.79M-0.56M1.23M5.27M-4.50M-1.76M2.08M0.50M1.19M
Change in Account PayablesChange Payables
1.37M0.13M0.27M-0.80M-0.33M2.07M-0.31M1.03M0.42M-1.22M0.22M1.04M-0.56M-0.38M-0.19M-0.61M0.41M1.31M-0.44M1.27M
Change in Accured ExpensesChange Accured Exp.
-0.25M-0.07M0.12M0.39M-0.46M-0.29M0.36M0.24M-0.18M-0.07M0.41M-0.27M-0.06M0.14M0.03M0.29M-0.76M0.39M1.16M-0.75M
Other Working Capital ChangesOther WC Changes
-0.78M0.65M2.57M-0.19M0.30M1.97M-0.38M-1.63M1.82M0.36M-1.24M-1.78M-0.09M0.70M4.52M-1.01M-2.09M-2.34M-1.17M
Investing Activities
Capital ExpendituresCapex
0.91M0.57M0.41M0.51M0.75M0.60M0.75M0.76M0.67M0.08M0.09M-0.00M0.09M0.33M-0.04M0.29M0.00M0.04M0.24M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.00M
Cash from Investing ActivitiesCash from Investing
-0.91M-0.57M-0.41M-0.51M-0.75M-0.60M-0.75M-0.76M-0.67M-0.08M-0.09M0.00M-0.09M-0.04M-0.25M-0.05M-0.24M-0.01M-0.24M
Financing Activities
Other financing activitiesOther financing
-0.00M0.01M0.24M0.00M0.28M0.04M0.01M0.02M0.21M0.00M
Cash from Financing ActivitiesCash from Financing
0.00M0.12M0.07M0.02M0.09M-0.07M-0.59M0.13M-0.03M-0.04M-0.04M0.24M-0.03M-0.01M0.17M-0.04M-0.02M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Exchange Rate EffectFX Effect
Change in Cash
-0.69M0.78M3.92M0.31M-0.95M2.77M0.82M-1.53M-5.25M0.64M-1.04M-1.85M0.27M-0.14M0.45M6.58M0.54M-1.81M-1.39M-2.25M
Free Cash FlowFCF
-0.69M0.66M3.85M0.29M-0.95M2.68M0.82M-1.45M-4.66M0.51M-1.01M-1.81M0.31M-0.38M0.16M6.91M0.31M-1.74M-1.38M-2.24M
Net Cash FlowNCF
-0.69M0.78M3.92M0.31M-0.95M2.77M0.82M-1.53M-5.25M0.64M-1.04M-1.85M0.27M-0.14M0.45M6.58M0.54M-1.81M-1.39M-2.25M